Apimeds Pharmaceuticals US Inc (APUS)

Ticker: APUS Exchange: ASE


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Apimeds Pharmaceuticals US Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
Kim Christopher Chairman and CMO Executive Director
Transaction date
Purchase
Price
224.18
Quantity 90,388 +44.1%
Value US$4,914,605
2.2
Kim Christopher Chairman and CMO Executive Director
Transaction date
Purchase
Price
219.15
Quantity 88,194 -20.8%
Value US$3,104,080
1.3
Koo Jakap Non-Executive Director
Transaction date
Purchase
Price
306.81
Quantity 44,972 +49.9%
Value US$1,821,767
Inscobee Inc. Large shareholder
Transaction date
Purchase
Price
4.00
Quantity 500,000 +33.7%
Value US$2,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-05-15 2025-05-14 B Purchase

Chairman and CMO

Executive Director
90,388 +44.1%
224.18
US$4,914,605
90,388 +44.1% 224.18 US$4,914,605
2025-05-15 2025-05-13 B Purchase

Chairman and CMO

Executive Director
88,194 -20.8%
219.15
US$3,104,080
88,194 -20.8% 219.15 US$3,104,080
2025-05-14 2025-05-12 B Purchase Non-Executive Director
44,972 +49.9%
306.81
US$1,821,767
44,972 +49.9% 306.81 US$1,821,767
2025-05-14 2025-05-12 B Purchase Large shareholder
500,000 +33.7%
4.00
US$2,000,000
500,000 +33.7% 4.00 US$2,000,000